ReviewJournal of atherosclerosis and thrombosis2019

Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases.

Shizuya Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.